Synapse News
McMaster University collaborating with Verv Technologies to advance blood testing technology, leveraging $314k grant from NSERC
Verv Technologies and McMaster University announced a new collaboration that will further develop Verv’s technology to improve at-home healthcare. A $314,000 investment from the Natural Sciences and Engineering Research Council of Canada is allowing the partners to work together to develop a series of blood tests that have the potential to…
Llif Healthcare and Chirp among Big Winners at at 12th Annual LiONS LAIR Awards Gala.
Congratulations to the 2022 LiONS LAIR winners, who collected $50,000. Innovation Factory’s LiONS LAIR event showcases the region’s innovative start-up community and gives up-and-coming entrepreneurs the opportunity to pitch their business to a panel of Hamilton’s top business experts and potential investors. Second place winner Shawn…
VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimer’s Disease
VoxNeuro Inc., a Hamilton-based commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, announced a new partnership with Boston University (“BU”), a world-class institution and private research university at the forefront of neuroscience and neurotechnology. In…
3 ways smart site selection is helping Life Sciences companies turn innovation into commercialization
Making a smart site selection could drive the commercialization of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialization.
Innovation Parks, Clinical Infrastructure and Supportive Networks are three ways smart site selection is helping life sciences companies turn innovation into commercialisation
Making a smart site selection could drive the commercialisation of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialisation. Three areas in particular, are making site selection easier: innovation parks, clinical infrastructure and…
SOPHIE participant Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants
Lactiga Therapeutics, an early-stage biotechnology company focused on improving the quality of life of patients with primary immunodeficiency diseases, announced this week that it has oversubscribed its pre-seed financing, raising $1.6 million in new capital including over $350,000 in research grants. The lead investor in the financing was…
Adapsyn Bioscience enters into strategic collaboration with Evotec
Adapsyn Bioscience Inc., a chemical bioinformatics company that discovers novel drug-like small molecules, today announced a strategic collaboration with Evotec SE. Under the collaboration, Evotec will have the opportunity to evaluate small molecules developed by Adapsyn as potential therapeutic candidates in proprietary and partnered drug…
OmniaBio Groundbreaking Ceremony
Thursday, October 6, 2022, from 10:00 am to 12:00 pm in Hamilton, Ontario Mitchel Sivilotti, President of OmniaBio, and Dr. Michael May, President and CEO of CCRM, invite you to attend OmniaBio’s groundbreaking and signing ceremony. OmniaBio will be Canada’s first and largest commercial-scale contract development and manufacturing…
Startups need cash, time, and connections
Alex Muggah has seen hundreds of life sciences and healthtech companies work to commercialize their innovations. If new healthcare innovations don’t integrate with existing systems, there is little to no chance of mass adoption. As Director of the Synapse Life Science Consortium, a partnership of public- and private-sector institutions in…